TECAGINLIMAB: 36 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
36
Total FAERS Reports
9 (25.0%)
Deaths Reported
36
Hospitalizations
36
As Primary/Secondary Suspect
5
Life-Threatening
First Report: 20230101 · Latest Report: 20240906
What Are the Most Common TECAGINLIMAB Side Effects?
#1 Most Reported
Febrile neutropenia
9 reports (25.0%)
#2 Most Reported
Pneumonia
6 reports (16.7%)
#3 Most Reported
Haemophagocytic lymphohistiocytosis
5 reports (13.9%)
All TECAGINLIMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 9 | 25.0% | 4 | 9 |
| Pneumonia | 6 | 16.7% | 1 | 6 |
| Haemophagocytic lymphohistiocytosis | 5 | 13.9% | 0 | 5 |
Who Reports TECAGINLIMAB Side Effects? Age & Gender Data
Gender: 61.5% female, 38.5% male. Average age: 64.0 years. Most reports from: ES. View detailed demographics →
Is TECAGINLIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2023 | 12 | 4 | 12 |
| 2024 | 24 | 5 | 24 |
What Is TECAGINLIMAB Used For?
| Indication | Reports |
|---|---|
| Non-small cell lung cancer | 8 |
| Squamous cell carcinoma of lung | 8 |
| Non-small cell lung cancer metastatic | 6 |
Official FDA Label for TECAGINLIMAB
Official prescribing information from the FDA-approved drug label.